Quick Biology
Private Company
Total funding raised: $1.2M
Overview
Quick Biology is a private, revenue-generating service provider in the genomics and diagnostics space. The company leverages established molecular biology techniques to offer essential research and diagnostic support services, positioning itself as a critical enabler for academic, biopharma, and clinical labs. Its model is based on delivering reliable, fast-turnaround genomic data generation and analysis, catering to the growing demand for outsourced specialized lab work. While not developing its own therapeutic pipeline, its success is tied to the broader expansion of precision medicine and genomic research.
Technology Platform
Integrated suite of molecular biology and genomic analysis services, including next-generation sequencing, PCR, and bioinformatics, optimized for rapid, high-quality research and diagnostic support.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Quick Biology operates in a highly fragmented and competitive market with large global CROs and genomics service providers (e.g., Azenta, Eurofins Scientific, Q2 Solutions) at one end and numerous small, specialized academic core facilities or boutique labs at the other. Differentiation is achieved through service quality, turnaround time, scientific expertise, and customer service rather than proprietary technology.